Analyst consensus rating
Immunocore Holdings Analyst Rating: Strong Buy
IMCR is rated Strong Buy by 12 analysts with a $62.50 target. As of 2026-09-03.
Direct answer
Immunocore Holdings's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $62.50.
Forecast evidence checked September 3, 2026.
Get free Immunocore Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $37.37
- Average price target
- $62.50
- High price target
- $100.00
- Low price target
- $34.00
- Low target gap
- -9%
- Target upside
- +67.2%
- High target gap
- +167.6%
- Target range width
- 176.6%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- September 3, 2026
- Valid through
- September 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Immunocore Holdings?
Immunocore Holdings has a verified Strong Buy consensus. The same dataset has an average price target of $62.50.
How far are Immunocore Holdings's low and high targets from the recorded price?
The low target implies -9%, while the high target implies +167.6%.
How many analysts are included in Immunocore Holdings's consensus?
The verified consensus includes 12 analysts.
How is Immunocore Holdings's target upside or downside calculated?
The average target of $62.50 is divided by the recorded price of $37.37, then one is subtracted to produce +67.2%. This does not guarantee a future return.
When was Immunocore Holdings's analyst forecast verified?
The data was verified on 2026-09-03. The dataset is valid through 2026-09-10.